跳至主要内容
临床试验/IRCT201205259855N1
IRCT201205259855N1已完成未知

Efficacy of N-Acetyl cystein in prevention of drug induced hepatitis in tuberculosis patient

Arak University of Medical sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 100 years(—)
性别
All

入选标准

  • age over 50 years; hemodynamic stability (mean arterial blood pressure >70 mmHg or systolic blood pressure >90mmHg ) Exclusion criteria: history of acute or chronic renal and liver failure accordance with the definitions of relevant, Unavailability of information related to liver function in basic mode, use of N- acetylcysteine orally, injected or inhaled during 1 month before the beginning of the study; Experience has confirmed that the incidence of hypersensitivity reactions following oral, intravenous or inhaled N- acetylcysteine; receiving concomitant drugs or compounds with antioxidant effects such as vitamin C, vitamin E; HIV + patients; use of alcohol

排除标准

  • 未提供

研究者

相似试验